Notice of Results

AI SummaryClose X

CelLBxHealth plc will announce its preliminary results for the year ended 31 December 2025 on Monday, 22 June 2026, with the Chief Executive Officer providing an overview via an online investor presentation at 11:00 BST on the same day. The company, a CTC intelligence specialist, focuses on circulating tumour cell solutions for research, drug development, and clinical oncology, utilizing its Parsortix platform across product sales, laboratory services, and lab-developed tests.

Disclaimer*

UK 100

Latest directors dealings